Withdrawn ID: | w63 |
---|---|
Canonical SMILES: | |
Standard InChI: | |
Standard InChIKey: | |
ATC class(es): | N |
Molecular Formula: | C11H15NO2 |
Molweight: | 193.242 |
Withdrawn due to drug safety reasons: | Yes |
---|---|
First withdrawn: | 1964 |
Last withdrawn: | 1964 |
Reference: | https://www.ncbi.nlm.nih.gov/pubmed/21574210 |
Total reported cases (submitted by medical professionals) with Butamben as primary suspect: | 18 |
---|
Hospitalization (initial or prolonged): | 8 |
---|---|
Life-Threatening condition: | 7 |
Disability: | 1 |
Intervention required to prevent permanent impairment/damage: | 1 |
Side-effect | Case number |
---|---|
METHAEMOGLOBINAEMIA | 9 |
HYPOXIA | 5 |
DYSPNOEA | 5 |
OXYGEN SATURATION DECREASED | 3 |
OROPHARYNGEAL PAIN | 2 |
ACQUIRED METHAEMOGLOBINAEMIA | 2 |
Fatigue | 2 |
PHARYNGEAL OEDEMA | 2 |
Cyanosis | 2 |
THROAT IRRITATION | 2 |
POST PROCEDURAL COMPLICATION | 1 |
Product expiration date issue | 1 |
SELF-MEDICATION | 1 |
Pallor | 1 |
SKIN DISCOLOURATION | 1 |
THROAT TIGHTNESS | 1 |
TREMOR | 1 |
INCORRECT DOSE ADMINISTERED | 1 |
NO REACTION ON PREVIOUS EXPOSURE TO DRUG | 1 |
INJURY | 1 |
HEART RATE INCREASED | 1 |
EYE ROLLING | 1 |
Dizziness | 1 |
DEPRESSED LEVEL OF CONSCIOUSNESS | 1 |
CONVULSION | 1 |
COMA | 1 |
BLOOD PRESSURE INCREASED | 1 |
Blood pressure decreased | 1 |
Blood methaemoglobin present | 1 |
Target UniProtKB ID | Activity in nm | Target Name | Target gene |
---|---|---|---|
P02545 | 7079.5 | Prelamin-A/C | LMNA_HUMAN |
Toxicity class: | 5 |
---|---|
Toxicity type: | dermatological |
LD50: | 5000 mg/kg |
ChEBML: | CHEMBL127516 |
---|---|
DrugBank: |